Genome-wide profiling of interleukin-4 and STAT6 transcription factor regulation of human Th2 cell programming

Immunity

Volumn 32, Issue 6, 2010, Pages 852-862

  Elo, Laura L ^a   Järvenpää, Henna ^a   Tuomela, Soile ^a   Raghav, Sunil ^a   Ahlfors, Helena ^a,b   Laurila, Kirsti ^c   Gupta, Bhawna ^a   Lund, Riikka J ^a,d   Tahvanainen, Johanna ^a   Hawkins, R David ^e   Orešič, Matej ^f   Lähdesmäki, Harri ^c,g   Rasool, Omid ^a   Rao, Kanury V ^a   Aittokallio, Tero ^h,i   Lahesmaa, Riitta ^a,i  

^a UNIVERSITY OF TURKU   (Finland)

^b ÅBO AKADEMI UNIVERSITY   (Finland)

^c TAMPERE UNIVERSITY OF TECHNOLOGY   (Finland)

^d UNIVERSITY OF SHEFFIELD   (United Kingdom)

^e UNIVERSITY OF CALIFORNIA   (United States)

^f VTT TECHNICAL RESEARCH CENTRE OF FINLAND   (Finland)

^g AALTO UNIVERSITY   (Finland)

^h INTERNATIONAL CENTRE FOR GENETIC ENGINEERING AND BIOTECHNOLOGY   (Italy)

ⁱ HARVARD MEDICAL SCHOOL   (United States)

Author keywords

MOLIMMUNO; SYSBIO

Indexed keywords

INTERLEUKIN 4; STAT6 PROTEIN;

ARTICLE; CD4+ T LYMPHOCYTE; CHROMATIN IMMUNOPRECIPITATION; CONTROLLED STUDY; HUMAN; HUMAN CELL; LYMPHOCYTE DIFFERENTIATION; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; REGULATORY MECHANISM; RNA INTERFERENCE; TH2 CELL; TRANSCRIPTION INITIATION; TRANSCRIPTION REGULATION;

CELL DIFFERENTIATION; GENE EXPRESSION; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENOME-WIDE ASSOCIATION STUDY; HUMANS; INTERLEUKIN-4; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; STAT6 TRANSCRIPTION FACTOR; TH2 CELLS; TRANSCRIPTION, GENETIC;

EID: 77953881949     PISSN: 10747613     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.immuni.2010.06.011     Document Type: Article

References (71)

1. Adamson A.S., Collins K., Laurence A., O'Shea J.J. The Current STATus of lymphocyte signaling: new roles for old players. Curr. Opin. Immunol. 2009, 21:161-166.
2. Agrawal B., Longenecker B.M. MUC1 mucin-mediated regulation of human T cells. Int. Immunol. 2005, 17:391-399.
3. Ahn H.J., Kim J.Y., Ryu K.J., Nam H.W. STAT6 activation by Toxoplasma gondii infection induces the expression of Th2 C-C chemokine ligands and B clade serine protease inhibitors in macrophage. Parasitol. Res. 2009, 105:1445-1453.
4. Andrews R.P., Ericksen M.B., Cunningham C.M., Daines M.O., Hershey G.K. Analysis of the life cycle of stat6. Continuous cycling of STAT6 is required for IL-4 signaling. J. Biol. Chem. 2002, 277:36563-36569.
5. Arpa L., Valledor A.F., Lloberas J., Celada A. IL-4 blocks M-CSF-dependent macrophage proliferation by inducing p21Waf1 in a STAT6-dependent way. Eur. J. Immunol. 2009, 39:514-526.
6. Benjamini Y., Hochberg Y. Controlling the False Discovery Rate: A Practical and Powerful Approach to Multiple Testing. J. R. Stat. Soc. Series B Stat Methodol. 1995, 57. 289-290, 300.
7. Bettelli E., Korn T., Kuchroo V.K. Th17: the third member of the effector T cell trilogy. Curr. Opin. Immunol. 2007, 19:652-657.
8. Betz B.C., Jordan-Williams K.L., Wang C., Kang S.G., Liao J., Logan M.R., Kim C.H., Taparowsky E.J. Batf coordinates multiple aspects of B and T cell function required for normal antibody responses. J. Exp. Med. 2010, 207:933-942.
9. Blanchette M., Bataille A.R., Chen X., Poitras C., Laganière J., Lefèbvre C., Deblois G., Giguère V., Ferretti V., Bergeron D., et al. Genome-wide computational prediction of transcriptional regulatory modules reveals new insights into human gene expression. Genome Res. 2006, 16:656-668.
10. Brunsing R., Omori S.A., Weber F., Bicknell A., Friend L., Rickert R., Niwa M. B- and T-cell development both involve activity of the unfolded protein response pathway. J. Biol. Chem. 2008, 283:17954-17961.
11. Büttner C., Skupin A., Rieber E.P. Transcriptional activation of the type I collagen genes COL1A1 and COL1A2 in fibroblasts by interleukin-4: analysis of the functional collagen promoter sequences. J. Cell. Physiol. 2004, 198:248-258.
12. Chaitidis P., Billett E.E., O'Donnell V.B., Fajardo A.B., Fitzgerald J., Kuban R.J., Ungethuem U., Kühn H. Th2 response of human peripheral monocytes involves isoform-specific induction of monoamine oxidase-A. J. Immunol. 2004, 173:4821-4827.
13. Chen Z., Lund R., Aittokallio T., Kosonen M., Nevalainen O., Lahesmaa R. Identification of novel IL-4/Stat6-regulated genes in T lymphocytes. J. Immunol. 2003, 171:3627-3635.
14. Cosmi L., Annunziato F., Nagata K., Romagnani S., Nagata K., Romagnani S. CRTH2 is the most reliable marker for the detection of circulating human type 2 Th and type 2 T cytotoxic cells in health and disease. Eur. J. Immunol. 2000, 30:2972-2979. Galli MIG, Maggi RMEMaggi RME.
15. Elo L.L., Lahti L., Skottman H., Kyläniemi M., Lahesmaa R., Aittokallio T. Integrating probe-level expression changes across generations of Affymetrix arrays. Nucleic Acids Res. 2005, 33:e193.
16. Fejes A.P., Robertson G., Bilenky M., Varhol R., Bainbridge M., Jones S.J. FindPeaks 3.1: a tool for identifying areas of enrichment from massively parallel short-read sequencing technology. Bioinformatics 2008, 24:1729-1730.
17. Filen J.J., Filen S., Moulder R., Tuomela S., Ahlfors H., West A., Kouvonen P., Kantola S., Björkman M., Katajamaa M., et al. Quantitative proteomics reveals GIMAP family proteins 1 and 4 to be differentially regulated during human T helper cell differentiation. Mol. Cell. Proteomics 2009, 8:32-44. Published online August 12, 2008. 10.1074/mcp.M800139-MCP200.
18. Gabay C., Porter B., Guenette D., Billir B., Arend W.P. Interleukin-4 (IL-4) and IL-13 enhance the effect of IL-1beta on production of IL-1 receptor antagonist by human primary hepatocytes and hepatoma HepG2 cells: differential effect on C-reactive protein production. Blood 1999, 93:1299-1307.
19. Gascoyne D.M., Long E., Veiga-Fernandes H., de Boer J., Williams O., Seddon B., Coles M., Kioussis D., Brady H.J. The basic leucine zipper transcription factor E4BP4 is essential for natural killer cell development. Nat. Immunol. 2009, 10:1118-1124.
20. Goenka S., Boothby M. Selective potentiation of Stat-dependent gene expression by collaborator of Stat6 (CoaSt6), a transcriptional cofactor. Proc. Natl. Acad. Sci. USA 2006, 103:4210-4215.
21. Hämäläinen H., Zhou H., Chou W., Hashizume H., Heller R., Lahesmaa R. Distinct gene expression profiles of human type 1 and type 2 T helper cells. Genome Biol. 2001, 2. RESEARCH0022.
22. Hebenstreit D., Luft P., Schmiedlechner A., Regl G., Frischauf A.M., Aberger F., Duschl A., Horejs-Hoeck J. IL-4 and IL-13 induce SOCS-1 gene expression in A549 cells by three functional STAT6-binding motifs located upstream of the transcription initiation site. J. Immunol. 2003, 171:5901-5907.
23. Hebenstreit D., Wirnsberger G., Horejs-Hoeck J., Duschl A. Signaling mechanisms, interaction partners, and target genes of STAT6. Cytokine Growth Factor Rev. 2006, 17:173-188.
24. Ji H., Jiang H., Ma W., Johnson D.S., Myers R.M., Wong W.H. An integrated software system for analyzing ChIP-chip and ChIP-seq data. Nat. Biotechnol. 2008, 26:1293-1300.
25. Johnson D.S., Mortazavi A., Myers R.M., Wold B. Genome-wide mapping of in vivo protein-DNA interactions. Science 2007, 316:1497-1502.
26. Kamizono S., Duncan G.S., Seidel M.G., Morimoto A., Hamada K., Grosveld G., Akashi K., Lind E.F., Haight J.P., Ohashi P.S., Look A.T., Mak T.W. Nfil3/E4bp4 is required for the development and maturation of NK cells in vivo. J. Exp. Med. 2009, 206:2977-2986.
27. Kaplan M.H., Schindler U., Smiley S.T., Grusby M.J. Stat6 is required for mediating responses to IL-4 and for development of Th2 cells. Immunity 1996, 4:313-319.
28. Khodarev N., Ahmad R., Rajabi H., Pitroda S., Kufe T., McClary C., Joshi M.D., MacDermed D., Weichselbaum R., Kufe D. Cooperativity of the MUC1 oncoprotein and STAT1 pathway in poor prognosis human breast cancer. Oncogene 2010, 29:920-929.
29. Kim S.H., Gunst K.V., Sarvetnick N. STAT4/6-dependent differential regulation of chemokine receptors. Clin. Immunol. 2006, 118:250-257.
30. Kitoh A., Ono M., Naoe Y., Ohkura N., Yamaguchi T., Yaguchi H., Kitabayashi I., Tsukada T., Nomura T., Miyachi Y., et al. Indispensable Role of the Runx1-Cbfbeta Transcription Complex for in vivo-suppressive function of FoxP3+ regulatory T cells. Immunity 2009, 31:609-620.
31. Komine O., Hayashi K., Natsume W., Watanabe T., Seki Y., Seki N., Yagi R., Sukzuki W., Tamauchi H., Hozumi K., et al. The Runx1 transcription factor inhibits the differentiation of naive CD4+ T cells into the Th2 lineage by repressing GATA3 expression. J. Exp. Med. 2003, 198:51-61.
32. Kurata H., Lee H.J., O'Garra A., Arai N. Ectopic expression of activated Stat6 induces the expression of Th2-specific cytokines and transcription factors in developing Th1 cells. Immunity 1999, 11:677-688.
33. Kwon H., Thierry-Mieg D., Thierry-Mieg J., Kim H.P., Oh J., Tunyaplin C., Carotta S., Donovan C.E., Goldman M.L., Tailor P., et al. Analysis of interleukin-21-induced Prdm1 gene regulation reveals functional cooperation of STAT3 and IRF4 transcription factors. Immunity 2009, 31:941-952.
34. Laajala T.D., Raghav S., Tuomela S., Lahesmaa R., Aittokallio T., Elo L.L. A practical comparison of methods for detecting transcription factor binding sites in ChIP-seq experiments. BMC Genomics 2009, 10:618.
35. Lee Y.H., Stallcup M.R. Interplay of Fli-I and FLAP1 for regulation of beta-catenin dependent transcription. Nucleic Acids Res. 2006, 34:5052-5059.
36. Li Z., Van Calcar S., Qu C., Cavenee W.K., Zhang M.Q., Ren B. A global transcriptional regulatory role for c-Myc in Burkitt's lymphoma cells. Proc. Natl. Acad. Sci. USA 2003, 100:8164-8169.
37. Li R., Li Y., Kristiansen K., Wang J. SOAP: short oligonucleotide alignment program. Bioinformatics 2008, 24:713-714.
38. Liao W., Schones D.E., Oh J., Cui Y., Cui K., Roh T.Y., Zhao K., Leonard W.J. Priming for T helper type 2 differentiation by interleukin 2-mediated induction of interleukin 4 receptor alpha-chain expression. Nat. Immunol. 2008, 9:1288-1296.
39. Lund R.J., Löytömäki M., Naumanen T., Dixon C., Chen Z., Ahlfors H., Tuomela S., Tahvanainen J., Scheinin J., Henttinen T., et al. Genome-wide identification of novel genes involved in early Th1 and Th2 cell differentiation. J. Immunol. 2007, 178:3648-3660.
40. Massie C.E., Mills I.G. ChIPping away at gene regulation. EMBO Rep. 2008, 9:337-343.
41. Matute J.D., Arias A.A., Wright N.A., Wrobel I., Waterhouse C.C., Li X.J., Marchal C.C., Stull N.D., Lewis D.B., Steele M., et al. A new genetic subgroup of chronic granulomatous disease with autosomal recessive mutations in p40 phox and selective defects in neutrophil NADPH oxidase activity. Blood 2009, 114:3309-3315.
42. McGaha T.L., Le M., Kodera T., Stoica C., Zhu J., Paul W.E., Bona C.A. Molecular mechanisms of interleukin-4-induced up-regulation of type I collagen gene expression in murine fibroblasts. Arthritis Rheum. 2003, 48:2275-2284.
43. Mole D.R., Blancher C., Copley R.R., Pollard P.J., Gleadle J.M., Ragoussis J., Ratcliffe P.J. Genome-wide association of hypoxia-inducible factor (HIF)-1alpha and HIF-2alpha DNA binding with expression profiling of hypoxia-inducible transcripts. J. Biol. Chem. 2009, 284:16767-16775.
44. Nagai S., Hashimoto S., Yamashita T., Toyoda N., Satoh T., Suzuki T., Matsushima K. Comprehensive gene expression profile of human activated T(h)1- and T(h)2-polarized cells. Int. Immunol. 2001, 13:367-376.
45. Naoe Y., Setoguchi R., Akiyama K., Muroi S., Kuroda M., Hatam F., Littman D.R., Taniuchi I. Repression of interleukin-4 in T helper type 1 cells by Runx/Cbf beta binding to the Il4 silencer. J. Exp. Med. 2007, 204:1749-1755.
46. Ohmori Y., Hamilton T.A. Interleukin-4/STAT6 represses STAT1 and NF-kappa B-dependent transcription through distinct mechanisms. J. Biol. Chem. 2000, 275:38095-38103.
47. Ohmori Y., Smith M.F., Hamilton T.A. IL-4-induced expression of the IL-1 receptor antagonist gene is mediated by STAT6. J. Immunol. 1996, 157:2058-2065.
48. Olsson L.M., Lindqvist A.K., Källberg H., Padyukov L., Burkhardt H., Alfredsson L., Klareskog L., Holmdahl R. A case-control study of rheumatoid arthritis identifies an associated single nucleotide polymorphism in the NCF4 gene, supporting a role for the NADPH-oxidase complex in autoimmunity. Arthritis Res. Ther. 2007, 9:R98.
49. Ouyang W., Ranganath S.H., Weindel K., Bhattacharya D., Murphy T.L., Sha W.C., Murphy K.M. Inhibition of Th1 development mediated by GATA-3 through an IL-4-independent mechanism. Immunity 1998, 9:745-755.
50. Rioux J.D., Xavier R.J., Taylor K.D., Silverberg M.S., Goyette P., Huett A., Green T., Kuballa P., Barmada M.M., Datta L.W., et al. Genome-wide association study identifies new susceptibility loci for Crohn disease and implicates autophagy in disease pathogenesis. Nat. Genet. 2007, 39:596-604.
51. Robertson G., Hirst M., Bainbridge M., Bilenky M., Zhao Y., Zeng T., Euskirchen G., Bernier B., Varhol R., Delaney A., et al. Genome-wide profiles of STAT1 DNA association using chromatin immunoprecipitation and massively parallel sequencing. Nat. Methods 2007, 4:651-657.
52. Rogge L., Bianchi E., Biffi M., Bono E., Chang S.Y., Alexander H., Santini C., Ferrari G., Sinigaglia L., Seiler M., et al. Transcript imaging of the development of human T helper cells using oligonucleotide arrays. Nat. Genet. 2000, 25:96-101.
53. Schaefer G., Venkataraman C., Schindler U. Cutting edge: FISP (IL-4-induced secreted protein), a novel cytokine-like molecule secreted by Th2 cells. J. Immunol. 2001, 166:5859-5863.
54. Schraml B.U., Hildner K., Ise W., Lee W.L., Smith W.A., Solomon B., Sahota G., Sim J., Mukasa R., Cemerski S., et al. The AP-1 transcription factor Batf controls T(H)17 differentiation. Nature 2009, 460:405-409.
55. Schröder A.J., Pavlidis P., Arimura A., Capece D., Rothman P.B. Cutting edge: STAT6 serves as a positive and negative regulator of gene expression in IL-4-stimulated B lymphocytes. J. Immunol. 2002, 168:996-1000.
56. Shimoda K., van Deursen J., Sangster M.Y., Sarawar S.R., Carson R.T., Tripp R.A., Chu C., Quelle F.W., Nosaka T., Vignali D.A., et al. Lack of IL-4-induced Th2 response and IgE class switching in mice with disrupted Stat6 gene. Nature 1996, 380:630-633.
57. Shinnakasu R., Yamashita M., Kuwahara M., Hosokawa H., Hasegawa A., Motohashi S., Nakayama T. Gfi1-mediated stabilization of GATA3 protein is required for Th2 cell differentiation. J. Biol. Chem. 2008, 283:28216-28225.
58. Spilianakis C.G., Flavell R.A. Long-range intrachromosomal interactions in the T helper type 2 cytokine locus. Nat. Immunol. 2004, 5:1017-1027.
59. Suriano A.R., Sanford A.N., Kim N., Oh M., Kennedy S., Henderson M.J., Dietzmann K., Sullivan K.E. GCF2/LRRFIP1 represses tumor necrosis factor alpha expression. Mol. Cell. Biol. 2005, 25:9073-9081.
60. Takatori H., Nakajima H., Hirose K., Kagami S., Tamachi T., Suto A., Suzuki K., Saito Y., Iwamoto I. Indispensable role of Stat5a in Stat6-independent Th2 cell differentiation and allergic airway inflammation. J. Immunol. 2005, 174:3734-3740.
61. Takeda K., Tanaka T., Shi W., Matsumoto M., Minami M., Kashiwamura S., Nakanishi K., Yoshida N., Kishimoto T., Akira S. Essential role of Stat6 in IL-4 signalling. Nature 1996, 380:627-630.
62. Toscano M.A., Bianco G.A., Ilarregui J.M., Croci D.O., Correale J., Hernandez J.D., Zwirner N.W., Poirier F., Riley E.M., Baum L.G., Rabinovich G.A. Differential glycosylation of TH1, TH2 and TH-17 effector cells selectively regulates susceptibility to cell death. Nat. Immunol. 2007, 8:825-834.
63. Weaver C.T., Harrington L.E., Mangan P.R., Gavrieli M., Murphy K.M. Th17: an effector CD4 T cell lineage with regulatory T cell ties. Immunity 2006, 24:677-688.
64. Yang Y., Ochando J., Yopp A., Bromberg J.S., Ding Y. IL-6 plays a unique role in initiating c-Maf expression during early stage of CD4 T cell activation. J. Immunol. 2005, 174:2720-2729.
65. Yssel H., De Vries J.E., Koken M., Van Blitterswijk W., Spits H. Serum-free medium for generation and propagation of functional human cytotoxic and helper T cell clones. J. Immunol. Methods 1984, 72:219-227.
66. Zhang S., Lukacs N.W., Lawless V.A., Kunkel S.L., Kaplan M.H. Cutting edge: differential expression of chemokines in Th1 and Th2 cells is dependent on Stat6 but not Stat4. J. Immunol. 2000, 165:10-14.
67. Zhang F., Meng G., Strober W. Interactions among the transcription factors Runx1, RORgammat and Foxp3 regulate the differentiation of interleukin 17-producing T cells. Nat. Immunol. 2008, 9:1297-1306.
68. Zhao H., Li C.C., Pardo J., Chu P.C., Liao C.X., Huang J., Dong J.G., Zhou X., Huang Q., Huang B., et al. A novel E3 ubiquitin ligase TRAC-1 positively regulates T cell activation. J. Immunol. 2005, 174:5288-5297.
69. Zhu J., Guo L., Watson C.J., Hu-Li J., Paul W.E. Stat6 is necessary and sufficient for IL-4's role in Th2 differentiation and cell expansion. J. Immunol. 2001, 166:7276-7281.
70. Zhu J., Guo L., Min B., Watson C.J., Hu-Li J., Young H.A., Tsichlis P.N., Paul W.E. Growth factor independent-1 induced by IL-4 regulates Th2 cell proliferation. Immunity 2002, 16:733-744.
71. Zhu J., Yamane H., Cote-Sierra J., Guo L., Paul W.E. GATA-3 promotes Th2 responses through three different mechanisms: induction of Th2 cytokine production, selective growth of Th2 cells and inhibition of Th1 cell-specific factors. Cell Res. 2006, 16:3-10.